Researchers are working to decrease the patient discomfort experienced during vaccination

Researchers are working to decrease the patient discomfort experienced during vaccination
An analysis of 45 million papers and 3.9 million patents since 1945 shows that the rate of disruptiveness in science is steeply declining.
It is generally accepted that a community of beneficial bacteria make up the lung microbiome, but their origin and formation have remained unclear — until now.
Stimulating neuron growth using a new mRNA therapy, researchers hope to treat chronic pain caused by disease, injury, or chemotherapy.
Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.
Using nanoparticles fitted with ACE2 receptors, researchers hope to lure SARS-CoV-2 away from healthy cells to inhibit the virus and treat infection.
New study provides evidence that social media companies have the tools to reduce the impact of vaccine misinformation on their platforms.
A fast and efficient means of record keeping could improve the ability to trace structural differences in viral variants.
Preliminary data indicates that booster shots improve antibody levels 25-fold compared to just two doses.
Antibody therapies and new vaccines have been added to the arsenal, giving hope to the millions who live where malaria is endemic.